This Pharma Stock is up 70% Pre-Market

(NASDAQ:VRNA) shares are soaring this morning on news, news, news. The company has an earnings call today, which will no doubt also include the discussions of a positive phase 3 study for COPD. The stock has surged to $11.90 this morning up 70% Volume is more than 4 million and there are more than 41,000 trades so far https://www.globenewswire.com/news-release/2022/08/09/2494468/0/en/Verona-Pharma-Announces-Ensifentrine-Meets-Primary-Endpoint-in-Phase-3-ENHANCE-2-Trial-for-COPD.html

[mstock id=”73007″ asset=”VRNA”]

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.